Pharmaceutical Executive
Life sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Shankar Suryanarayanan
Advertisement
Articles by Shankar Suryanarayanan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration’s Leadership Carousel Across Key Agencies
2
FDA Approves Foundayo Under National Priority Voucher Program
3
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
4
More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf
5